King Georges Medical University

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Osteoporosis1 trial
• Ovarian cancer1 trial
• Stroke1 trial

Phase

• Phase 22 trials
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Amgen1 trial
• CanariaBio Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

  NCT05605535· Phase 2· CanariaBio Inc.· Source

Closed trials

• Completed

  A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

  NCT06079476· Phase 4· Amgen· Source

• Completed

  A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

  NCT04172675· Phase 2· Janssen Research & Development, LLC· Source